PT Pyridam Farma Tbk (ISX:PYFA) Cyclically Adjusted FCF per Share: Rp-25.11 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:PYFA PT Pyridam Farma Tbk ISX:PYFA
65 GF Score
Price Rp210.00
GF Value Rp211.81
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is PT Pyridam Farma Tbk Cyclically Adjusted FCF per Share?

PT Pyridam Farma Tbk ISX:PYFA +3.96% 65 Cyclically Adjusted FCF per Share is Rp-25.11 as of Mar. 2026. GuruFocus rates ISX:PYFA with a GF Score™ of 65/100 and a GF Value™ of Rp211.81 (Fairly Valued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

PT Pyridam Farma Tbk's adjusted free cash flow per share for the three months ended in Mar. 2026 was Rp-18.638. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is Rp-25.11 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -34.80% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -76.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of PT Pyridam Farma Tbk was -29.10% per year. The lowest was -166.60% per year. And the median was -100.40% per year.

As of today (2026-08-01), PT Pyridam Farma Tbk's current stock price is Rp210.00. PT Pyridam Farma Tbk's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was Rp-25.11. PT Pyridam Farma Tbk's Cyclically Adjusted Price-to-FCF of today is .


PT Pyridam Farma Tbk  (ISX:PYFA) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


PT Pyridam Farma Tbk Cyclically Adjusted FCF per Share Related Terms


PT Pyridam Farma Tbk Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for PT Pyridam Farma Tbk's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Pyridam Farma Tbk Cyclically Adjusted FCF per Share Chart

PT Pyridam Farma Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.01 -9.47 -13.74 -17.22 -23.21

PT Pyridam Farma Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.88 -20.61 -22.06 -23.21 -25.11

ISX:PYFA vs ZTS, UTHR, VTRS: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PT Pyridam Farma Tbk's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Pyridam Farma Tbk Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Pyridam Farma Tbk's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where PT Pyridam Farma Tbk's Cyclically Adjusted Price-to-FCF falls into.


ISX:PYFA
65GF Score
PT Pyridam Farma Tbk ISX:PYFA
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Pyridam Farma Tbk Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PT Pyridam Farma Tbk's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-18.638/136.5387*136.5387
=-18.638

Current CPI (Mar. 2026) = 136.5387.

PT Pyridam Farma Tbk Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.132 103.212 -0.175
201609 1.950 104.142 2.557
201612 1.285 105.222 1.667
201703 -1.580 106.476 -2.026
201706 1.729 107.722 2.192
201709 3.971 108.020 5.019
201712 2.948 109.017 3.692
201803 -6.387 110.097 -7.921
201806 -1.684 111.085 -2.070
201809 -0.296 111.135 -0.364
201812 2.088 112.430 2.536
201903 -0.894 112.829 -1.082
201906 0.814 114.730 0.969
201909 1.430 114.905 1.699
201912 4.340 115.486 5.131
202003 -0.708 116.252 -0.832
202006 1.273 116.630 1.490
202009 -3.577 116.397 -4.196
202012 0.314 117.318 0.365
202103 -0.524 117.840 -0.607
202106 -6.496 118.184 -7.505
202109 -9.000 118.262 -10.391
202112 -57.188 119.516 -65.333
202203 -22.894 120.948 -25.845
202206 -28.905 123.322 -32.003
202209 -22.563 125.298 -24.587
202212 57.916 126.098 62.711
202303 -10.184 126.953 -10.953
202306 -13.806 127.663 -14.766
202309 -6.413 128.151 -6.833
202312 -20.814 129.395 -21.963
202403 -12.703 130.607 -13.280
202406 15.587 130.792 16.272
202409 -13.722 130.361 -14.372
202412 -22.934 131.432 -23.825
202503 -14.088 131.948 -14.578
202506 -14.093 133.241 -14.442
202509 -13.405 133.819 -13.677
202512 -5.122 135.271 -5.170
202603 -18.638 136.539 -18.638

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of Rp-25.11 mean?
PT Pyridam Farma Tbk (ISX:PYFA) has a Cyclically Adjusted FCF per Share of Rp-25.11 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on PT Pyridam Farma Tbk and its competitors.
Is PT Pyridam Farma Tbk's Cyclically Adjusted FCF per Share too high?
PT Pyridam Farma Tbk's current Cyclically Adjusted FCF per Share is Rp-25.11. Overall, PT Pyridam Farma Tbk has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Pyridam Farma Tbk's Cyclically Adjusted FCF per Share compare to ZTS and UTHR?
PT Pyridam Farma Tbk's Cyclically Adjusted FCF per Share of Rp-25.11 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on PT Pyridam Farma Tbk and its competitors. PT Pyridam Farma Tbk's current Cyclically Adjusted FCF per Share is Rp-25.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Pyridam Farma Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Pyridam Farma Tbk (ISX:PYFA) is currently considered Fairly Valued. The stock's GF Value™ is Rp211.81, compared to a current price of Rp210.00 — trading 0.9% below its estimated fair value. The current Cyclically Adjusted FCF per Share is Rp-25.11. PT Pyridam Farma Tbk's overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For PT Pyridam Farma Tbk (ISX:PYFA), the current Cyclically Adjusted FCF per Share is Rp-25.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Pyridam Farma Tbk (ISX:PYFA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Pyridam Farma Tbk stock appears to be undervalued. The current stock price of Rp210.00 is trading 0.9% below its estimated GF Value™ of Rp211.81. GuruFocus considers PT Pyridam Farma Tbk to be Fairly Valued.

Key valuation signals for ISX:PYFA:

  • Cyclically Adjusted FCF per Share: Rp-25.11
  • GF Value™: Rp211.81 vs. price of Rp210.00 (0.9% below fair value)
  • GF Score™: 65/100 with 8 warning signs

No single metric tells the full story. See the ISX:PYFA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Pyridam Farma Tbk Business Description

Address Jl. Jenderal Sudirman Kav. 21, Sinar Mas Land Plaza Sudirman 12th Floor, RT 10/RW 01 Kuningan, Karet, Jakarta Selatan, Jakarta, IDN, 12920
PT Pyridam Farma Tbk is engaged in the production and development of pharmaceutical medicines and the trading of medical equipment. It manufactures products namely Antibiotics, Vitamins, Supplements, and Traditional herbal care. It operates through two segments namely Pharmaceutical products, Esthetics, and Toll manufacturing services; and Medical equipment Products segment. The company derives maximum revenue from Pharmaceutical products, Esthetics, and Toll manufacturing services. The company's products include consumer health, Derma, prescription, and biomedilab.
65GF Score

Get the complete analysis for ISX:PYFA

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp210.00
Price
Rp211.81
GF Value